Warner Chilcott Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Dublin Ireland (1996)
Status: Acquired by Actavis (2013) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2000
NCT00073021
First Marketed Drug
1996
cyanocobalamin (berocca)
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

WARNER CHILCOTT | Warner Chilcott Laboratories | WARNER CHILCOTT LLC | Warner Chilcott (US) LLC | Warner Chilcott (v2)

Active Ingredients

Marketed Drugs (43)

Key: Warner Chilcott (39) Acquired (4)

acetaminophen (tylenol) (1978)

acetic acid (vosol) (1979)

albuterol (proventil)

amitriptyline (elavil)

calcium carbonate (2005)

carbamazepine (tegretol)

cefadroxil (duricef) (1978 NDA)

chlorthalidone (Hygroton)

clonidine (catapres)

clorazepate (tranxene) (1988)

codeine (Phenergan) (1978)

cyanocobalamin (berocca) (1949)

diazepam (valium)

diphenhydramine (benadryl)

dopamine (intropin)

doxycycline (vibramycin) (1985)

erythromycin (ilosone) (1981)

estradiol (progynon depot) (2003)

ethinyl estradiol (Estinyl) (1975)

fenoprofen (nalfon)

flurazepam (dalmane)

furosemide (lasix)

hydrochlorothiazide (esidrix) (1988)

kanamycin (Kantrex)

lidocaine (xylocaine) (2005)

lorazepam (ativan) (1988)

norethindrone (1975)

nystatin (mycostatin)

oxtriphylline (choledyl) (1981)

phenytoin (mesantoin)

procainamide (pronestyl)

propoxyphene (Darvon)

propranolol (inderal) (1988)

quinidine

risedronate (actonel) (2005)

selenium

spironolactone (aldactone)

tetracaine (pontocaine) (2005)

tetracycline (tetrex) (1973)

theophylline (synophylate)

thyroglobulin (proloid) (1953 NDA)

urea (1980)

verapamil (calan) (1986)

Drugs in Phase 4 Trials (19)

Key: Warner Chilcott (1) Acquired (18)

bismuth subsalicylate (Pepto-Bismol) (3 trials)

calcium (2 trials)

darifenacin (enablex) (7 trials)

dextromethorphan (delsym) (1 trial)

diphenhydramine (benadryl) (1 trial)

doxycycline (vibramycin) (3 trials)

erdosteine (1 trial)

lansoprazole (prevacid) (1 trial)

mesalamine (rowasa) (13 trials)

monofluorophosphate (8 trials)

omeprazole (prilosec) (2 trials)

prednisone (meticorten) (1 trial)

psyllium (4 trials)

risedronate (actonel) (34 trials)

sodium bicarbonate (1 trial)

sodium fluoride (18F) (7 trials)

stannous fluoride (5 trials)

tolterodine (detrol) (2 trials)

vitamin d3 (3 trials)

Drugs in Phase 3 Trials (13)

Key: Warner Chilcott (6) Acquired (7)

azimilide (7 trials)

bifidobacterium infantis (3 trials)

b multivitamins (1 trial)

conjugated equine estrogens (Premarin) (1 trial)

desonide (1 trial)

eculizumab (Soliris) (2 trials)

estradiol (progynon depot) (6 trials)

ethinyl estradiol (Estinyl) (5 trials)

norethindrone (5 trials)

sarecycline (4 trials)

sotalol (betapace) (1 trial)

testosterone (delatestryl) (9 trials)

udenafil (5 trials)

Drugs in Phase 2 Trials (12)

Key: Warner Chilcott (1) Acquired (11)

alendronic acid (fosamax) (2 trials)

alprostadil (prostin) (1 trial)

bifidobacterium longum (1 trial)

ibandronate (boniva) (1 trial)

naronapride (2 trials)

nitrofurantoin (furadantin) (1 trial)

olestra (Olean) (1 trial)

pg-116800 (1 trial)

pg-530742 (1 trial)

pg-760564 (3 trials)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 1 Trials (4)

Key: Warner Chilcott (0) Acquired (4)

acetaminophen (tylenol) (1 trial)

codeine (Phenergan) (1 trial)

doxylamine (1 trial)

nefopam (Acupan) (1 trial)

Drugs in Other Trials (19)

Key: Warner Chilcott (0) Acquired (19)

bifidobacterium animalis (1 trial)

cellulose (1 trial)

cetylpyridinium chloride (1 trial)

chlorhexidine (hibitane) (1 trial)

denosumab (prolia) (1 trial)

folic acid (1 trial)

iron (1 trial)

lactobacillus (1 trial)

mentha piperita (1 trial)

nigella sativa (1 trial)

oxalate (3 trials)

petrolatum, white (Vaseline) (1 trial)

potassium nitrate (2 trials)

sodium chloride (3 trials)

sodium fluoride (2 trials)

tin difluoride (10 trials)

turmeric (1 trial)

vitamin c (1 trial)

water (1 trial)

Indications

Approved Indications


 

Bacterial Infections

Infections

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Atrophy (Phase 3)

Bone Diseases, Metabolic (Phase 3)

Chlamydia Infections (Phase 3)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Communicable Diseases (Phase 3)

Diverticulitis (Phase 2)

Dyspareunia (Phase 3)

Erectile Dysfunction (Phase 3)

Heart Failure (Phase 2)

Hot Flashes (Phase 3)

Hyperplasia (Phase 2)

Hypokinesia (Phase 3)

Infections (Phase 3)

Infertility (Phase 1)

Lower Urinary Tract Symptoms (Phase 2)

Osteogenesis Imperfecta (Phase 3)

Osteoporosis (Phase 4)

Osteoporosis, Postmenopausal (Phase 3)

Prostatic Hyperplasia (Phase 2)

Psychomotor Agitation (Phase 2)

Sexual Dysfunctions, Psychological (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 156
  • # of Trial APIs: 67